Header cover image

German (DAX) Biotech Industry Analysis

UpdatedJun 13, 2025
DataAggregated Company Financials
Companies11
  • 7D2.5%
  • 3M7.8%
  • 1Y-30.3%
  • YTD-31.2%

In the last week, the Biotech industry is up 2.5%, with Formycon up 2.9%. During this same period, the 4SC underperformed, falling 17%. In contrast, the industry has lost 30% in the last 12 months. Earnings are forecast to grow by 50% annually.

Industry Valuation and Performance

Has the German Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 13 Jun 2025€923.8m€137.5m-€154,499,093.004.1x-6x6.7x
Sun, 11 May 2025€2.2b€836.4m-€143,205,717.0024.1x-15.5x2.7x
Tue, 08 Apr 2025€2.2b€818.3m-€158,890,276.0029.2x-13.7x2.7x
Thu, 06 Mar 2025€2.2b€791.9m€73.0m13.8x30.7x2.8x
Sat, 01 Feb 2025€2.7b€791.8m€74.2m14.8x36.5x3.4x
Mon, 30 Dec 2024€2.6b€791.8m€74.2m14.5x35.4x3.3x
Wed, 27 Nov 2024€2.6b€791.8m€74.2m13.2x34.5x3.2x
Fri, 25 Oct 2024€2.6b€866.1m€170.2m11.9x15.4x3x
Sun, 22 Sep 2024€2.6b€867.2m€174.8m11.9x14.7x3x
Tue, 20 Aug 2024€2.5b€868.4m€171.3m13.6x14.8x2.9x
Thu, 18 Jul 2024€2.7b€885.2m€215.0m12.4x12.5x3x
Sat, 15 Jun 2024€2.6b€884.7m€210.7m10.8x12.2x2.9x
Mon, 13 May 2024€2.6b€884.7m€210.7m10x12.1x2.9x
Wed, 10 Apr 2024€2.7b€773.3m€10.4m9x257x3.5x
Fri, 08 Mar 2024€2.6b€747.5m-€56,275,600.0012x-46.9x3.5x
Sun, 04 Feb 2024€2.7b€769.9m-€145,885,802.0013.1x-18.7x3.5x
Tue, 02 Jan 2024€2.9b€769.9m-€145,885,802.0013.5x-19.7x3.7x
Thu, 30 Nov 2023€2.9b€779.7m-€160,010,802.0013.6x-18.3x3.8x
Sat, 28 Oct 2023€3.8b€955.3m-€172,995,145.0011.5x-21.9x4x
Mon, 25 Sep 2023€3.9b€971.6m-€197,588,171.0011x-19.8x4x
Wed, 23 Aug 2023€4.1b€947.8m-€36,633,772.0019.3x-110.9x4.3x
Fri, 21 Jul 2023€4.2b€955.7m-€219,213,323.0028.4x-19.3x4.4x
Sun, 18 Jun 2023€4.2b€967.4m-€212,883,319.0030x-19.7x4.3x
Tue, 16 May 2023€4.0b€967.4m-€209,726,026.0035.2x-18.8x4.1x
Thu, 13 Apr 2023€3.6b€920.1m-€215,202,347.0013.9x-16.8x3.9x
Sat, 11 Mar 2023€2.9b€612.1m-€74,266,181.0010.1x-38.9x4.7x
Mon, 06 Feb 2023€3.0b€612.1m-€74,509,505.0010.9x-40.6x4.9x
Wed, 04 Jan 2023€3.0b€611.9m-€53,407,435.0011.2x-56.7x4.9x
Fri, 02 Dec 2022€3.0b€611.9m-€53,407,435.0011.1x-56.7x4.9x
Sun, 30 Oct 2022€2.6b€627.4m-€129,805,157.005.8x-19.8x4.1x
Tue, 27 Sep 2022€2.5b€627.4m-€129,805,157.005.1x-19.5x4x
Thu, 25 Aug 2022€2.8b€605.7m-€150,021,513.006.2x-18.4x4.6x
Sat, 23 Jul 2022€3.4b€772.0m-€724,268,362.00n/a-4.7x4.5x
Mon, 20 Jun 2022€3.3b€768.8m-€724,082,241.00n/a-4.5x4.3x
Price to Earnings Ratio

-4.5x


Total Market Cap: €3.3bTotal Earnings: -€724,082,241.00Total Revenue: €768.8mTotal Market Cap vs Earnings and Revenue0%0%0%
German Biotech Industry Price to Earnings3Y Average -9.3x202320242025
Current Industry PE
  • Investors are optimistic on the German Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 3.8x is lower than the industry's current PS ratio of 6.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 44% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market-2.10%
Healthcare1.01%
Biotech2.51%
Biotech2.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FYB Formycon€28.202.9%
+€14.1m
-41.7%PS7.1x
HPHA Heidelberg Pharma€4.735.1%
+€10.7m
62.5%PS32.2x
MDG1 Medigene€0.1128.1%
+€367.7k
-95.6%PS0.2x
CNW co.don€0.0224.8%
+€26.7k
100.0%n/a
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

FYB

€28.20

Formycon

7D

2.9%

1Y

-41.7%

20B

€0.18

Biomark Diagnostics

7D

-1.6%

1Y

33.3%

HPHA

€4.73

Heidelberg Pharma

7D

5.1%

1Y

62.5%

MDG1

€0.11

Medigene

7D

28.1%

1Y

-95.6%

VSC

€1.06

4SC

7D

-16.9%

1Y

-86.3%

CNW

€0.022

co.don

7D

4.8%

1Y

100.0%